P/E at 62.39 vs Industry's 61.47: What the Data Shows for Apollo Hospitals Enterprise Ltd.

Valuation Picture: Premium Reflecting Sector Confidence

The current P/E of 62.39 for Apollo Hospitals Enterprise Ltd. sits slightly above the hospital industry average of 61.47. This premium, though not excessive, suggests that investors are willing to pay a marginally higher price for the stock relative to its peers. Such a valuation often reflects expectations of sustained earnings growth or superior operational performance within the sector. However, the narrow gap between the stock’s P/E and the industry average also indicates that the market’s optimism is tempered by sector-wide challenges or competitive pressures. Apollo Hospitals’s valuation thus aligns closely with sector norms, raising the question previously rated Hold, what is Apollo Hospitals’ current rating?

Performance Across Timeframes: Strong Long-Term Gains Amid Short-Term Stability

Examining returns over multiple periods reveals a compelling growth trajectory for Apollo Hospitals Enterprise Ltd.. The stock has delivered a robust 21.43% gain over the past year, vastly outperforming the Sensex’s 6.93% loss during the same period. This outperformance extends over longer horizons, with three-year returns at 68.90% versus the Sensex’s 21.26%, five-year returns at 165.79% compared to 44.92%, and an impressive ten-year return of 552.94% against the Sensex’s 189.31%. Such sustained growth underscores the company’s ability to generate shareholder value over time.

In the short term, the stock’s momentum remains positive but more subdued. Over the past three months, Apollo Hospitals has gained 14.88%, outperforming the Sensex’s 3.11% rise. The one-month and one-week returns of 1.86% and 0.98% respectively also surpass the Sensex’s 1.27% and -1.02%. Even on the most recent trading day, the stock edged up 0.32%, slightly ahead of the Sensex’s 0.22% increase. This consistent outperformance across timeframes highlights resilience, though the pace of gains has moderated recently — is this a genuine recovery or a relief rally that will fade at the 50 DMA?

Moving Average Configuration: Bullish Across All Key Averages

The technical picture for Apollo Hospitals Enterprise Ltd. is notably constructive. The stock is trading above all major moving averages — the 5-day, 20-day, 50-day, 100-day, and 200-day moving averages. This alignment suggests a strong upward trend and confirms the stock’s recent momentum is supported by both short-term and long-term technical indicators. Being close to its 52-week high, just 1.22% shy of Rs 8,624.2, further reinforces the positive technical stance. The stock has also recorded two consecutive days of gains, accumulating a 0.58% return in this period, indicating sustained buying interest.

Such a configuration often signals a continuation of the upward trend, but the question remains should investors in Apollo Hospitals hold, buy more, or reconsider?

Sector Context: Hospital Industry Showing Mixed but Generally Positive Trends

The hospital sector, to which Apollo Hospitals Enterprise Ltd. belongs, has exhibited a broadly positive performance in recent months. While exact sector-wide performance figures vary, the industry P/E of 61.47 indicates a valuation level consistent with steady growth expectations. Within this context, Apollo Hospitals’s slight premium suggests it is viewed as a leading player, benefiting from scale, brand recognition, and operational efficiencies. The sector’s mixed results, with some companies facing headwinds from regulatory changes and cost pressures, highlight the relative strength of Apollo Hospitals’s positioning.

Rating Context: Previously Rated Hold, Now Reassessed

MarketsMOJO had previously assigned a Hold rating to Apollo Hospitals Enterprise Ltd.. This rating was updated on 11 May 2026, reflecting a reassessment of the company’s fundamentals, valuation, and technical outlook. The current Mojo Score stands at 78.0, indicating a favourable overall assessment. The rating update coincides with the stock’s strong performance and technical strength, but the precise nature of the rating change is not disclosed. This leaves investors to analyse the data themselves and consider what the current rating implies for portfolio positioning?

Conclusion: Data Reflects a Stock with Strong Long-Term Growth and Technical Momentum

The data for Apollo Hospitals Enterprise Ltd. paints a picture of a large-cap hospital stock trading at a slight valuation premium relative to its industry peers. Its long-term performance is impressive, with returns well above the Sensex across one, three, five, and ten-year periods. The stock’s technical configuration is robust, trading above all key moving averages and near its 52-week high, signalling sustained momentum. The sector backdrop is generally positive, though mixed, underscoring the company’s relative strength. Having been previously rated Hold, the recent reassessment and current Mojo Score of 78.0 invite investors to consider whether this stock remains a core holding or warrants a fresh evaluation.

Get 33% Off on our 1 Year Plan - Limited Period Only! Start Today